Sudden progression from impaired glucose tolerance to type 2 diabetes after discontinuation of administration of anti-tumor necrosis factor-alpha antibody infliximab.
Ursini
F
F
Succurro
E
E
Grembiale
A
A
Rudi
S
S
Grembiale
R D
RD
Arturi
F
F